Bioscript Group (backed by Sovereign Capital Partners) Acquires Meridian HealthComms
April 19, 2022
Bioscript Group, a Sovereign Capital Partners-backed healthcare communications platform headquartered in Macclesfield, has acquired Meridian HealthComms. The deal is Bioscript's third acquisition since Sovereign backed the management team in March 2021 and expands the group's geographic footprint and service capabilities in medical communications, regulatory writing and market access.
- Buyers
- Bioscript Group, Sovereign Capital Partners
- Targets
- Meridian HealthComms
- Platforms
- Bioscript Group
- Industry
- Healthcare Services
- Location
- England, United Kingdom
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Sovereign Capital Partners Invests in Bioscript
March 4, 2021
Healthcare Services
Sovereign Capital Partners has completed a significant investment in Bioscript, a Macclesfield-based medical communications and regulatory writing agency, partnering with the management team to accelerate growth. The capital will support service development and geographic expansion as Bioscript looks to grow its UK and international presence.
-
SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B
July 7, 2022
Medical Devices
A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.
-
Pace Life Sciences Acquires Meridian BioGroup
August 18, 2022
Healthcare Services
Pace Life Sciences, a CDMO and subsidiary of Pace Science and Technology Company, has acquired Meridian BioGroup, a validation, regulatory, and compliance consulting provider based in Frederick, Maryland. The deal expands Pace's regulatory, quality and validation capabilities to better support biotechnology and pharmaceutical clients across development and commercialization.
-
MedComms Experts Acquires NexGen Healthcare Communications
July 24, 2025
Healthcare Services
MedComms Experts (backed by The Brydon Group) has acquired NexGen Healthcare Communications, a UK-headquartered medical communications agency. The deal combines complementary capabilities in medical, commercial and patient engagement communications to scale offerings across the US, UK and EU and strengthen the platform's tech-enabled services.
-
Lucid Group Acquires HealthCare21
September 12, 2019
Healthcare Services
Lucid Group, backed by private equity partner LDC, has acquired HealthCare21, a 23-year-old healthcare communications consultancy. The add-on expands Lucid's scientific, editorial and digital capabilities and increases its footprint in the North West of the United Kingdom while supporting broader international reach.
-
Velocity Clinical Research Acquires Meridian Clinical Research
December 15, 2022
Healthcare Services
Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.